Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - CNBC
business 2026/02/23 11:40:07

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion - CNBC

Source:CNBC
Author:Reuters

Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in ​its largest deal since 2020, the ​biopharma company said on ​Monday.